Loss of Response to Anti-Tumor Necrosis Factors: What Is the Next Step?

Publisher： Karger

E-ISSN： 1421-9875|32|4|384-388

ISSN： 0257-2753

Source： Digestive Diseases, Vol.32, Iss.4, 2014-06, pp. : 384-388

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Physiological Intermolecular Modification Spectroscopy for the Prediction of Response to Anti-Tumor Necrosis Factor Therapy in Patients with Inflammatory Bowel Diseases

By  

Digestive Diseases, Vol. 32, Iss. 4, 2014-06 ,pp. : 446-454

Karger

Access to resources Recommend Favorite

Suboptimal Clinical Response to Anti-tumor Necrosis Factor alpha (TNFα) Antibody Therapy in a Patient with Severe Rheumatoid Arthritis and Lymphadenopathy: CASE REPORT

By Saeki Yukihiko   Ohshima Shiro   Mima Toru   Sasai Mitsuko   Nishioka Katsuhiro   Shimizu Masatoshi   Suemura Masaki   McCloskey Richard   Kishimoto Tadamitsu  

Scandinavian Journal of Rheumatology, Vol. 27, Iss. 4, 1998-08 ,pp. : 303-305

Informa Healthcare

Access to resources Recommend Favorite

Anti-Tumor Necrosis Factor Nonresponders in Crohn’s Disease: Therapeutic Strategies

By  

Digestive Diseases, Vol. 27, Iss. 3, 2009-09 ,pp. : 351-357

Karger

Access to resources Recommend Favorite

Anti-Tumor Necrosis Factor Blocking Agents in the Treatment of Systemic Vasculitis

By  

Current Immunology Reviews, Vol. 7, Iss. 4, 2011-11 ,pp. : 423-428

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Tumor Necrosis Factor-amp;#945; Therapy in Undifferentiated Spondyloarthritis (USpA)

By  

Current Rheumatology Reviews, Vol. 5, Iss. 3, 2009-08 ,pp. : 174-176

Bentham Science Publishers

Access to resources Recommend Favorite